During the past decade, The Permanente Medical Group-Roseville Radiation Oncology conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 37 clinical trials were completed, i.e. on average, 57.8% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 18 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Permanente Medical Group-Roseville Radiation Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 31 trials, followed by "Radiation Therapy Oncology Group" with 27 trials sponsored, "NRG Oncology" with 18 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored and "Alliance for Clinical Trials in Oncology" with 8 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Permanente Medical Group-Roseville Radiation Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "NRG Oncology" with 36 trials as a collaborator, "Radiation Therapy Oncology Group" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "The Permanente Medical Group-Roseville Radiation Oncology" are "Prostate Cancer" (10 trials), "Head and Neck Cancer" (6 trials), "Stage II Breast Cancer" (5 trials), "Breast Cancer" (4 trials) and "Lung Non-Squamous Non-Small Cell Carcinoma" (4 trials). Many other conditions were trialed in "The Permanente Medical Group-Roseville Radiation Oncology" in a lesser frequency.

Most popular intervention types in "The Permanente Medical Group-Roseville Radiation Oncology" are "Drug" (72 trials), "Radiation" (56 trials), "Other" (45 trials), "Biological" (33 trials) and "Procedure" (25 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (20 trials), "Questionnaire Administration" (14 trials), "Carboplatin" (12 trials) and "Cisplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "The Permanente Medical Group-Roseville Radiation Oncology" are 73 trials for "All" genders, 14 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "The Permanente Medical Group-Roseville Radiation Oncology". undefined are not yet recruiting, 23 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in The Permanente Medical Group-Roseville Radiation Oncology, 4 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The Permanente Medical Group-Roseville Radiation Oncology, 1 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".